Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 1, 2009, Pages 94-98

  Deveci, Koksal ^a   Sogut, Erkan ^b   Evliyaoglu, Osman ^c   Duras, Nuriye ^c  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Rize Devlet Hastanesi   (Turkey)

^c Beydagi State Hospital   (Turkey)

Author keywords

C reactive protein; Pre eclampsia; Pregnancy associated plasma protein A

Indexed keywords

C REACTIVE PROTEIN; PLASMA PREGNANCY ASSOCIATED PLASMA PROTEIN A; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MEAN ARTERIAL PRESSURE; NEPHELOMETRY; PARITY; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; THIRD TRIMESTER PREGNANCY;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES;

EID: 58849115528     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00835.x     Document Type: Article

References (28)

1. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000 183 : 1 22.
2. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynecol 1992 99 : 547 553.
3. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynec Ann 1972 1 : 177 191.
4. Overgaard MZ, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 2000 275 : 31126 31133.
5. Bonno M, Oxving C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L. Localization of pregnancy-associated protein-A and colocalization of pregnancy-associated protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 1994 71 : 560 566.
6. Folkersen J, Grudzinskas JG, Hindersson P, Teisner B, Westergaard JG. Pregnancy-associated protein-A circulating levels during normal pregnancy. Am J Obstet Gynecol 1981 139 : 910 914.
7. Suzana MA, Francisco RM, Daliana PB. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003 123 : 2043 2049.
8. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999 180 : 499 506.
9. John CC, Luca F, Iqbal SM, Dorion OH. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001 285 : 1607 1612.
10. Terán E, Escudero C, Moya W, Flores M, Vallance P, López-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001 75 : 243 249.
11. López-Jaramillo P, Narváez M, Calle A et al. Cyclic guanosine 3=, 5= monophosphate concentrations in pre-eclampsia: effects of hydralazine. Br J Obstet Gynaecol 1996 103 : 33 38.
12. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997 82 : 1582 1588.
13. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003 107 : 1632 1639.
14. Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998 16 : 75 92.
15. Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T. Glucose intolerance in women with preeclampsia. Acta Obstet Gynecol Scand 1998 77 : 22 27.
16. Herrera JA, Chaudhuri G, López-Jaramillo P. Is infection a major risk for preeclampsia? Med Hypotheses 2001 57 : 393 397.
17. Williams M, Farrand A, Mittendorf R, Sorensen T, Zingheim R, Reily CO. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55(sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999 149 : 323 329.
18. Kluft C, de Maat MP. Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein. Vascul Pharmacol 2002 39 : 99 104.
19. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003 59 : 29 37.
20. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004 17 : 154 160.
21. Ustun Y, Ustun TE, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol RB 2005 121 : 154 158.
22. Lin TM, Halbert SP, Kiefer D, Spellacy WN. Characterization of four pregnancy-associated plasma proteins. Am J Gynecol 1974 118 : 223 236.
23. Klopper A. Biological and clinical aspects of PAPP-A. In : Grudzinskas JG, Teisner B, Seppala M (eds). Pregnancy Proteins. Sydney : Australia Academic Press, 1982 333 344.
24. Bersinger NA, Groome N, Muttukrishna S. Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with preeclampsia at term. Eur J Endocrinol 2002 147 : 785 793.
25. Bersinger NA, Smárason AK, Muttukrishna S, Groome NP, Redman CW. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy 2003 22 : 45 55.
26. Dugoff L, Hobbins JC, Malone FD et al. First trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial). Am J Obstet Gynecol 2004 191 : 1446 1451.
27. Okerengwo AA, Williams AI, Ibeziako PA. Immunological studies on preeclampsia in Nigerian women. Int J Gynaecol Obstet 1990 33 : 121 125.
28. Schjetlein R, Haugen G, Wissloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997 76 : 541 546.